Co‐ablation versus cryoablation for the treatment of stage III–IV non‐small cell lung cancer: A prospective, noninferiority, randomized, controlled trial (RCT)

BACKGROUND: This study compared a co‐ablation (CA) system, which is a novel ablation device, with an argon‐helium cryoablation (AHC) system. We aimed to compare the efficacy and safety of CA and AHC for the treatment of stage III–IV non‐small cell lung cancer (NSCLC). METHODS: We conducted a multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wuwei, An, Yonghui, Li, Quanwang, Liu, Chuanbo, Zhu, Baorang, Huang, Qianfu, Zhao, Mengfei, Yang, Fei, Feng, Huasong, Hu, Kaiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882381/
https://www.ncbi.nlm.nih.gov/pubmed/33319493
http://dx.doi.org/10.1111/1759-7714.13779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882381/
https://www.ncbi.nlm.nih.gov/pubmed/33319493
http://dx.doi.org/10.1111/1759-7714.13779

Ejemplares similares